News

Filter

Current filters:

Australia

26 to 35 of 97182 results

UK’s NICE recommends Pfizer’s Inlyta for kidney cancer

UK’s NICE recommends Pfizer’s Inlyta for kidney cancer

16-12-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) has issued new…

InlytaOncologyPfizerPharmaceuticalPricingRegulationUK

Sophiris Bio shares slide on Phase III results of PRX302

Sophiris Bio shares slide on Phase III results of PRX302

16-12-2014

Biotech company Sophiris Bio saw shares in the company fall up to almost 80% following an announcement…

BiotechnologyMen's HealthPRX302ResearchSophiris Bio

Actavis files emergency appeal against District Court decision on Namenda

Actavis files emergency appeal against District Court decision on Namenda

16-12-2014

Ireland-headquartered generics major Actavis is filing an emergency appeal to the US Court of Appeals…

ActavisGenericsLegalNamendaNeurologicalUSA

Astellas Venture Management invests in Crescendo's Humabody antibody fragment project

Astellas Venture Management invests in Crescendo's Humabody antibody fragment project

16-12-2014

UK-based antibody therapeutics specialist Crescendo Biologics has received another equity investment…

BiotechnologyBusiness FinanceCrescendo BiologicsOncologyUK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

16-12-2014

A new biomedical laboratory, the Biomedical Innovation Hub (the BioHub) has opened in Birmingham, UK.

BiotechnologyBirminghamResearchUKUnited Kingdom

Added benefit of Eylea over Lucentis in DME not proven, says IQWiG

Added benefit of Eylea over Lucentis in DME not proven, says IQWiG

16-12-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) has compared trial data on German…

BayerEyleaGermanyLucentisNovartisOphthalmicsPharmaceuticalPricingRegulationRoche

UK NICE partially backs Bayer’s Xofigo in preliminary assessment

UK NICE partially backs Bayer’s Xofigo in preliminary assessment

15-12-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) have recommended…

BayerOncologyPharmaceuticalPricingRegulationUKXofigo

OPKO Health leaps on potential $570 million deal with Pfizer

OPKO Health leaps on potential $570 million deal with Pfizer

15-12-2014

US drugmaker OPKO Health saw its shares leap 13.8% in pre-market trading, when it revealed a licensing…

LicensingOPKO HealthPfizerPharmaceuticalRare diseasesUSA

Sorrento to partner with Nantworks founder Patrick Soon-Shiong on immunomodulatory antibodies

Sorrento to partner with Nantworks founder Patrick Soon-Shiong on immunomodulatory antibodies

15-12-2014

Oncology specialist Sorrento Therapeutics has entered into a binding agreement with medical technology…

BiotechnologyLicensingOncologyResearchSorrento TherapeuticsUSA

26 to 35 of 97182 results

Back to top